NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
ID: 350658Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350658

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-051.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for investigator-initiated low-risk clinical trials focused on communication disorders through the National Institute on Deafness and Other Communication Disorders (NIDCD). This initiative, identified as PAR-24-051, aims to support well-designed research that contributes to the diagnosis, prevention, or treatment of conditions affecting hearing, speech, and language, with trials required to meet specific criteria such as not necessitating FDA oversight and being categorized as low-risk. The funding opportunity is significant for advancing health research and improving public health outcomes related to communication disorders, with a maximum budget of $500,000 in direct costs and a project duration of up to five years. Interested applicants must submit their proposals by January 5, 2024, with subsequent submission cycles until the closing date of January 8, 2028; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-051-Full-Announcement.html
    PAR-24-051.html
    The Department of Health and Human Services is issuing a funding opportunity through the National Institute on Deafness and Other Communication Disorders (NIDCD) for investigator-initiated, low-risk clinical trials targeting communication disorders. This initiative, identified as PAR-24-051, invites applications for well-designed research that can contribute significantly to the diagnosis, prevention, or treatment of conditions affecting hearing, speech, and language. The proposed trials must meet specific criteria: they should not necessitate FDA oversight, be categorized as low-risk, and gather data for further investigational studies rather than aiming to change established health policies or standards of care. Application budgets are capped at $500,000 in direct costs, with a maximum project duration of five years. Proposals will undergo a stringent peer review to ensure scientific merit and adherence to NIDCD's mission. The key submission date for new applications is January 5, 2024, with subsequent cycles outlined for the year until the expiration date of January 8, 2028. This funding opportunity aligns with the NIH's broader commitment to advancing health research and enhancing public health outcomes regarding communication disorders.
    Similar Opportunities
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering a funding opportunity titled "NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)." This initiative aims to support cooperative agreements for clinical trials that require FDA oversight, are intended to establish efficacy, or present higher risks to participants, with a budget exceeding $700,000. The funding is crucial for advancing clinical practices in treating communication disorders, emphasizing the inclusion of diverse populations in recruitment and retention strategies. Interested applicants, including various educational and nonprofit organizations, must submit their applications by January 27, 2024, and can find more information at NIH Grants.
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Deafness and Other Communication Disorders (NIDCD) for cooperative agreements aimed at supporting clinical trials in communication disorders. Applicants are required to propose a single clinical trial that may necessitate FDA oversight, demonstrate efficacy, or involve higher risks, with an emphasis on substantial interaction with NIDCD staff and comprehensive protections for human subjects. This initiative is crucial for advancing research and establishing effective treatments for conditions related to hearing, balance, taste, smell, voice, speech, and language. Interested applicants can access further details and guidelines through the announcement available at NIH Grants, with a budget that may exceed $700,000 in specific circumstances and a closing date for applications set for October 18, 2027.
    NIDCD Research Opportunities for New Investigators to Promote Workforce Development (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Deafness and Other Communication Disorders (NIDCD) to support R01 grant applications aimed at promoting workforce development among Early Stage and New Investigators in the field of communication disorders. This initiative encourages applications from individuals from diverse backgrounds, particularly those underrepresented in health-related sciences, and allows for innovative research projects without the necessity of preliminary data, provided they demonstrate feasibility. Applicants can request up to $500,000 in direct costs per year, with a total funding commitment of approximately $2.1 million planned for fiscal years 2026 and 2027 to support around 7-8 meritorious projects. Key application dates begin on January 6, 2025, with a closing date of October 6, 2026; for further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional) aimed at advancing the diagnosis, prevention, treatment, and amelioration of human sensory and communication disorders. This funding opportunity supports integrated, multidisciplinary research programs that include 3-4 synergistic research projects and an administrative core, with the possibility of 1-2 optional scientific cores, all centered around a unifying clinical theme. The maximum project period is five years, with budgets capped at $1,500,000 in direct costs per year for new applications. Eligible applicants include various organizations, excluding foreign entities, and are encouraged to consult with NIDCD staff prior to submission to ensure responsiveness. The application deadline is June 2, 2028, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering research grants aimed at translating basic research findings into clinical practice, specifically for communication disorders. This funding opportunity encourages collaborations between basic scientists and clinicians to develop practical applications that address hearing, balance, smell, taste, voice, and language disorders, with a focus on milestone-driven proposals that demonstrate a clear connection to clinical conditions and impactful outcomes. The grants, limited to a maximum of $500,000 in direct costs annually, are expected to support 2-3 awards in FY25, with applications due by October 12, 2027. Interested applicants can find more information and submit their proposals through Grants.gov, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to re-issue a Notice of Funding Opportunity (NOFO) for the Early-Stage Dissemination and Implementation Research in Communication Disorders, aimed at small businesses. This grant opportunity, utilizing the R21 activity code, focuses on research that seeks to bridge the gap between evidence-based innovations (EBIs) and their adoption in clinical practice and everyday life, specifically in the areas of hearing, balance, taste, smell, voice, speech, and language. With an estimated total program funding of $1,000,000, this initiative encourages collaborative investigations and aims to lay the groundwork for future high-quality R01 applications in the NIDCD mission areas. Interested applicants can reach out to Dr. Holly L. Storkel at holly.storkel@nih.gov or by phone at 301-496-5061 for further information, with the synopsis expected to be posted on August 8, 2025, and applications anticipated to close by October 10, 2025.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" aimed at stimulating research related to communication disorders associated with HIV/AIDS. This initiative encourages innovative, hypothesis-driven research that addresses high-priority areas such as hearing, speech, and language, with a focus on low-risk clinical trials that do not require FDA oversight. Eligible applicants include a wide range of organizations, such as higher education institutions and community-based organizations, with funding available up to $499,999 per year for projects lasting up to five years. Interested parties should submit their applications by January 7, 2026, and can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the announcement page at https://grants.nih.gov/grants/guide/pa-files/PAR-23-099.html.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD," aimed at stimulating research related to HIV/AIDS and communication disorders. This initiative encourages applications that address high-priority research areas defined by the NIH Office of AIDS Research, focusing on the impact of HIV on hearing, balance, taste, smell, voice, speech, and language, with a budget limit of $275,000 for a two-year project period. Eligible applicants include a diverse range of institutions and organizations, and only low-risk clinical trials that do not require FDA oversight will be supported. Interested parties can find more information and application details at the NIH grants website, with deadlines for submissions ranging from May 2025 to January 2028.
    NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Clinical Research Center Grant (P50 Clinical Trial Optional) aimed at advancing research in the areas of hearing, balance, smell, taste, voice, speech, or language. This grant encourages small businesses to form multidisciplinary teams that will collaborate on a synergistic set of 3-4 research projects addressing a unifying theme related to sensory and communication disorders. The initiative is designed to foster innovative solutions to complex clinical problems through integrated research efforts, supported by an administrative core and optional scientific cores. Interested applicants should note that while applications are not currently being solicited, they are encouraged to prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis posting date of August 6, 2025, and a close date of October 7, 2025. For further inquiries, potential applicants can contact Holly Storkel, Ph.D., at holly.storkel@nih.gov or by phone at 301-496-5061.